Eye Movements in Macular Degeneration.

adaptation fixation stability macular degeneration oculomotor reference saccade smooth pursuit

Journal

Annual review of vision science
ISSN: 2374-4650
Titre abrégé: Annu Rev Vis Sci
Pays: United States
ID NLM: 101660822

Informations de publication

Date de publication:
15 09 2021
Historique:
pubmed: 27 5 2021
medline: 24 3 2022
entrez: 26 5 2021
Statut: ppublish

Résumé

In healthy vision, the fovea provides high acuity and serves as the locus for fixation achieved through saccadic eye movements. Bilateral loss of the foveal regions in both eyes causes individuals to adopt an eccentric locus for fixation. This review deals with the eye movement consequences of the loss of the foveal oculomotor reference and the ability of individuals to use an eccentric fixation locus as the new oculomotor reference. Eye movements are an integral part of everyday activities, such as reading, searching for an item of interest, eye-hand coordination, navigation, or tracking an approaching car. We consider how these tasks are impacted by the need to use an eccentric locus for fixation and as a reference for eye movements, specifically saccadic and smooth pursuit eye movements.

Identifiants

pubmed: 34038144
doi: 10.1146/annurev-vision-100119-125555
pmc: PMC8916065
mid: NIHMS1779588
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

773-791

Subventions

Organisme : NEI NIH HHS
ID : R01 EY027390
Pays : United States
Organisme : NEI NIH HHS
ID : K99 EY026994
Pays : United States
Organisme : NEI NIH HHS
ID : F32 EY025151
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY022394
Pays : United States
Organisme : NEI NIH HHS
ID : R00 EY026994
Pays : United States

Références

Ophthalmic Physiol Opt. 2008 Mar;28(2):168-77
pubmed: 18339049
J Opt Soc Am A Opt Image Sci Vis. 2002 Jan;19(1):223-8
pubmed: 11778728
Exp Brain Res. 2011 May;210(3-4):569-82
pubmed: 21298423
Clin Ophthalmol. 2009;3:155-66
pubmed: 19668560
Invest Ophthalmol Vis Sci. 2012 Sep 25;53(10):6600-9
pubmed: 22930725
Vision Res. 1992 Feb;32(2):365-73
pubmed: 1574851
Vision Res. 2017 Dec;141:181-190
pubmed: 28057580
Vision (Basel). 2018 Apr 13;2(2):
pubmed: 31735883
Invest Ophthalmol Vis Sci. 2011 Jan 21;52(1):411-6
pubmed: 20811056
J Vis. 2016;16(3):1
pubmed: 26830707
J Rehabil Res Dev. 1999 Oct;36(4):356-64
pubmed: 10678458
Invest Ophthalmol Vis Sci. 2006 Jan;47(1):169-78
pubmed: 16384959
Vision Res. 1984;24(1):25-32
pubmed: 6695503
J Neuroophthalmol. 1999 Jun;19(2):84-8
pubmed: 10380128
Ophthalmic Physiol Opt. 2004 Jul;24(4):327-33
pubmed: 15228511
Invest Ophthalmol Vis Sci. 1990 Jun;31(6):1149-61
pubmed: 2354915
Ophthalmology. 2005 Sep;112(9):1579-85
pubmed: 16087239
Vision Res. 1998 Dec;38(23):3785-94
pubmed: 9893807
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1728-35
pubmed: 18385097
J Vis. 2007 Feb 27;7(3):6
pubmed: 17461684
Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):38
pubmed: 32543666
Invest Ophthalmol Vis Sci. 2011 Feb 28;52(2):1164-70
pubmed: 21087972
Vision Res. 2001 Mar;41(6):725-43
pubmed: 11248262
Invest Ophthalmol Vis Sci. 2014 Jul 29;55(8):5125-33
pubmed: 25074769
Ophthalmology. 1997 Apr;104(4):632-8
pubmed: 9111255
Optom Vis Sci. 2012 Sep;89(9):1385-94
pubmed: 22885785
J Neurophysiol. 2002 Jun;87(6):2936-45
pubmed: 12037197
Curr Biol. 2013 Sep 9;23(17):1663-9
pubmed: 23954427
Ophthalmology. 2006 Dec;113(12):2251-8
pubmed: 16996593
Optom Vis Sci. 2014 Aug;91(8):1000-11
pubmed: 25014364
Arch Ophthalmol. 1988 Nov;106(11):1543-7
pubmed: 3190538
Br J Ophthalmol. 2002 Sep;86(9):1019-26
pubmed: 12185131
J Neurophysiol. 2004 Feb;91(2):591-603
pubmed: 14762145
J Physiol. 1961 Dec;159:326-38
pubmed: 14490422
Invest Ophthalmol Vis Sci. 2011 May 05;52(6):2938-44
pubmed: 21296824
Vision Res. 2014 Mar;96:75-86
pubmed: 24456805
Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7603-9
pubmed: 21873676
Vision Res. 1994 Jul;34(13):1723-33
pubmed: 7941378
J Neurosci. 2019 May 1;39(18):3529-3536
pubmed: 30814310
J Fr Ophtalmol. 2016 Jan;39(1):82-9
pubmed: 26707755
Semin Pediatr Neurol. 2017 May;24(2):104-109
pubmed: 28941524
J Vestib Res. 1992 Fall;2(3):193-212
pubmed: 1342395
J Neurophysiol. 2020 Jul 1;124(1):134-144
pubmed: 32519572
Clin Exp Optom. 2020 Sep;103(5):648-655
pubmed: 31698519
Vision Res. 2005 Sep;45(20):2685-703
pubmed: 16005932
Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):27-37
pubmed: 17882447
Optom Vis Sci. 2013 Jan;90(1):45-56
pubmed: 23238260
Invest Ophthalmol Vis Sci. 1988 Feb;29(2):268-78
pubmed: 3338884
Optom Vis Sci. 2018 Jan;95(1):60-69
pubmed: 29252901
Prog Neurobiol. 1993 Oct;41(4):435-72
pubmed: 8210413
Vis Neurosci. 2005 Mar-Apr;22(2):187-201
pubmed: 15935111
J Vis. 2016 Dec 1;16(15):29
pubmed: 28027382
J Vis. 2013 Sep 12;13(3):
pubmed: 24029899
J Rehabil Res Dev. 1999 Oct;36(4):294-302
pubmed: 10678452
J Vis. 2019 Dec 2;19(14):20
pubmed: 31868895
J Neurophysiol. 2016 Mar;115(3):1220-7
pubmed: 26631148
Acta Ophthalmol. 2011 Feb;89(1):e82-8
pubmed: 21272283
J Neurophysiol. 2006 Jan;95(1):418-27
pubmed: 16162830
J Comp Physiol A. 1999 Oct;185(4):341-52
pubmed: 10555268
Optom Vis Sci. 2016 May;93(5):510-20
pubmed: 26829260
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6832-8
pubmed: 26513497
Vision Res. 1978;18(9):1165-72
pubmed: 716236
Vision Res. 1999 Feb;39(4):873-9
pubmed: 10341972
Exp Eye Res. 2019 Jun;183:3-8
pubmed: 30012507
J Physiol. 2011 Apr 1;589(Pt 7):1627-42
pubmed: 21300755
Ophthalmic Physiol Opt. 2020 Mar;40(2):171-186
pubmed: 31925832
Invest Ophthalmol Vis Sci. 1978 May;17(5):465-8
pubmed: 640792
Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):815-821
pubmed: 29484559
J Neurosci. 2017 Nov 22;37(47):11469-11484
pubmed: 29054879
J Neurophysiol. 2018 Aug 1;120(2):489-496
pubmed: 29668381
Optom Vis Sci. 1995 Feb;72(2):125-38
pubmed: 7753526
Vision Res. 2007 Oct;47(23):2943-55
pubmed: 17881032
J Vis. 2016;16(6):10
pubmed: 27089065
Vision Res. 2008 Feb;48(4):577-88
pubmed: 18191983
Vision Res. 2003 Apr;43(9):971-82
pubmed: 12676241
Exp Brain Res. 1994;99(2):302-8
pubmed: 7925810
J Vis. 2016 Dec 1;16(15):23
pubmed: 28006073
J Neurosci. 2020 Jul 8;40(28):5465-5470
pubmed: 32487694
Front Psychol. 2013 Sep 03;4:579
pubmed: 24027546
Optom Vis Sci. 2012 Sep;89(9):1395-8
pubmed: 22863789
Invest Ophthalmol Vis Sci. 1991 Jun;32(7):2020-9
pubmed: 2055696
J Vis. 2021 Mar 1;21(3):9
pubmed: 33666643
J Opt Soc Am A Opt Image Sci Vis. 1995 Oct;12(10):2286-92
pubmed: 7500210
J Vis. 2017 Jan 1;17(1):33
pubmed: 28129416

Auteurs

Preeti Verghese (P)

The Smith-Kettlewell Eye Research Institute, San Francisco, California 94115, USA; email: preeti@ski.org.

Cécile Vullings (C)

The Smith-Kettlewell Eye Research Institute, San Francisco, California 94115, USA; email: preeti@ski.org.

Natela Shanidze (N)

The Smith-Kettlewell Eye Research Institute, San Francisco, California 94115, USA; email: preeti@ski.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH